Seeger Weiss Appointed Co-Lead in Intel CPU Litigation

Seeger Weiss partner Chris Seeger was appointed today Interim Co-Lead Counsel in the nationwide lawsuit against Intel, on behalf of consumers who purchased computers and other devices containing Intel computer chips. The Federal Court overseeing the litigation appointed Seeger to represent putative class members against multinational corporation Intel Corp. Plaintiffs claim that the company’s processors […]

June 15, 2018

integrated microchip

Seeger Weiss partner Chris Seeger was appointed today Interim Co-Lead Counsel in the nationwide lawsuit against Intel, on behalf of consumers who purchased computers and other devices containing Intel computer chips.

The Federal Court overseeing the litigation appointed Seeger to represent putative class members against multinational corporation Intel Corp. Plaintiffs claim that the company’s processors suffer from inherent security flaws, and that their downloadable “patch” considerably slows processing speeds and does not even fix the security vulnerabilities.

Serious security flaws in most Intel computer processors were discovered last year by Google’s Project Zero team in conjunction with researchers from several countries, potentially impacting millions of computers, servers, cloud operating systems and cellphones that were made over the last decade.

Unprecedented in scope, this is considered one of the worst and most widespread design flaws ever found, expected to affect untold millions of users.

Shockingly, it is also possible that Intel either knew or had reason to believe that a security defect existed in its CPUs for months or even years before disclosing the fact to consumers, thereby defrauding them as well as willfully exposing them to a multitude of risks and injuries, considering computers’ widespread and diverse use.

The case is In re Intel Corp. CPU Marketing, Sales Practices and Products Liability Litigation, MDL No. 2828 (D. Oregon).

 

To learn out more, visit our case page or call us at 877-912-2668.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More